Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Lung transplantation.

E P Trulock1

  • 1Department of Medicine, Washington University School of Medicine, St. Louis, Missouri 63110.

Annual Review of Medicine
|January 1, 1992
PubMed
Summary
This summary is machine-generated.

Lung transplantation is a viable treatment for end-stage lung disease patients. This review covers recipient selection, optimal timing, and outcomes for lung transplant success.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The role of C4d deposition in the diagnosis of antibody-mediated rejection after lung transplantation.

American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons·2017
Same author

Psychosocial Predictors of Mortality Following Lung Transplantation.

American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons·2015
Same author

A randomized, double-blind, placebo-controlled, multicenter study of rabbit ATG in the prophylaxis of acute rejection in lung transplantation.

American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons·2014
Same author

Antibodies to K-α 1 tubulin and collagen V are associated with chronic rejection after lung transplantation.

American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons·2012
Same author

A shift in the collagen V antigenic epitope leads to T helper phenotype switch and immune response to self-antigen leading to chronic lung allograft rejection.

Clinical and experimental immunology·2011
Same author

Clinical outcomes of solid organ transplant recipients with ehrlichiosis.

Transplant infectious disease : an official journal of the Transplantation Society·2009
Same journal

Dupilumab Emerges as an Effective Antibody Therapy for Eosinophilic Esophagitis.

Annual review of medicine·2026
Same journal

CAR T Cell Toxicities and Emerging Treatment Strategies.

Annual review of medicine·2026
Same journal

Transthyretin Amyloid Cardiomyopathy: A Rapidly Evolving Landscape.

Annual review of medicine·2026
Same journal

Accessibility of Somatic Genetic Testing for Cancer Treatment Decisions.

Annual review of medicine·2026
Same journal

Diffuse Parenchymal Lung Disease: Updates in Pathophysiology and Management.

Annual review of medicine·2026
Same journal

Revascularization for Ischemic Cardiomyopathy: Disproving the 45-Year-Old Concept of Hibernating Myocardium.

Annual review of medicine·2026
See all related articles

Area of Science:

  • Pulmonary Medicine
  • Surgical Innovation
  • Transplant Surgery

Background:

  • End-stage lung disease necessitates advanced treatment options.
  • Lung transplantation has emerged as a critical therapeutic pathway.
  • Patient selection and procedural timing are crucial for success.

Purpose of the Study:

  • To summarize recipient selection guidelines for lung transplantation.
  • To discuss the optimal timing for performing lung transplants.
  • To review functional outcomes and survival rates post-transplantation.

Main Methods:

  • Review of current recipient selection criteria.
  • Analysis of factors influencing transplantation timing.
  • Compilation and assessment of published functional and survival data.

Related Experiment Videos

Main Results:

  • Established guidelines exist for selecting appropriate lung transplant candidates.
  • Specific clinical indicators guide the timing of lung transplantation.
  • Functional results and survival statistics demonstrate the efficacy of the procedure in selected patients.

Conclusions:

  • Lung transplantation is a well-established option for carefully chosen patients.
  • Adherence to selection guidelines and appropriate timing are key.
  • Outcomes data support the continued use of lung transplantation for end-stage lung disease.